A 32-year-old farmer is brought to the emergency department by his wife. The patient was reportedly anxious, sweaty, and complaining of a headache and chest tightness before losing consciousness on route to the hospital. Which of the following is mechanistically responsible for this patient's symptoms?
Q62
A drug research team has synthesized a novel oral drug that acts as an agonist at multiple adrenergic receptors. When administered in animals, it has been shown to produce urinary retention at therapeutic doses with the absence of other manifestations of adrenergic stimulation. The researchers are interested in understanding signal transduction and molecular mechanisms behind the action of the novel drug. Which of the following receptors would most likely transduce signals across the plasma membrane following the administration of this novel drug?
Q63
A 20-year-old man visits the clinic for a regular follow-up appointment. Patient says he has been experiencing dry mouth and flushing of his skin for the past few days. He also feels tired and sleepy most of the time. Past medical history is significant for a skin rash a couple weeks ago after eating strawberries, for which he has prescribed a medication that he is still taking. Which of the following is the most likely etiology of this patient’s symptoms?
Q64
A 35-year-old man comes to the physician because of dull abdominal pain on his right side for 4 months. He also reports episodic nausea and vomiting during this period. He does not have fever, altered bowel habits, or weight loss. He has had a pet dog for 8 years. He appears healthy. Vital signs are within normal limits. Abdominal examination shows a nontender mass 3 cm below the right costal margin that moves with respiration. Laboratory studies show:
Hemoglobin 14.6 g/dL
Leukocyte count 7200/mm3
Segmented neutrophils 58%
Eosinophils 8%
Lymphocytes 30%
Monocytes 4%
Ultrasound of the abdomen shows a focal hypoechoic cyst within the liver measuring 7 cm. An ELISA confirms the diagnosis. He is scheduled for CT-guided percutaneous drainage under general anesthesia with orotracheal intubation. Seven minutes into the procedure, the patient's oxygen saturation suddenly decreases from 95% to 64%. His heart rate is 136/min, and blood pressure is 86/58 mm Hg. Examination shows diffuse expiratory wheezing bilaterally with poor air movement. Which of the following is most appropriate next step in management?
Q65
A 24-year-old woman presents to her primary care physician for bilateral nipple discharge. She states that this started recently and seems to be worsening. She denies any other current symptoms. The patient states that she is not currently sexually active, and her last menstrual period was over a month ago. Her medical history is notable for atopic dermatitis and a recent hospitalization for an episode of psychosis. Her temperature is 99.5°F (37.5°C), blood pressure is 110/65 mmHg, pulse is 70/min, respirations are 15/min, and oxygen saturation is 98% on room air. Cardiopulmonary and abdominal exam are within normal limits. Which of the following is the most likely cause of this patient's symptoms?
Q66
A 19-year-old man is brought to the emergency department by his mother because of increasing agitation and aggression at home. He has a history of bipolar disorder. During the last week, he has refused to take his lithium medication because it makes him “feel empty inside.” The mother thinks he has experimented with illicit drugs in the past. He appears acutely agitated, yells at multiple medical staff members, and demands to be discharged. His temperature is 37.7°C (99.8°F), pulse is 95/min, respirations are 18/min, and blood pressure is 140/75 mm Hg. Haloperidol is administered and the patient is admitted. The next morning, the patient reports worsening neck pain. He states that his neck is locked to the left and he cannot move it. Examination shows rigidity of his upper body and neck, with the neck fixed in flexion and rotated to the left. Administration of which of the following is the most appropriate next step in the management of this patient?
Q67
A previously healthy 25-year-old woman comes to the physician because of a 1-month history of palpitations that occur on minimal exertion and sometimes at rest. She has no chest discomfort or shortness of breath. She feels nervous and irritable most of the time and attributes these feelings to her boyfriend leaving her 2 months ago. Since then she has started exercising more frequently and taking an herbal weight-loss pill, since which she has lost 6.8 kg (15 lb) of weight. She finds it hard to fall asleep and awakens 1 hour before the alarm goes off each morning. She has been drinking 2 to 3 cups of coffee daily for the past 7 years and has smoked one pack of cigarettes daily for the past 3 years. Her temperature is 37.4°C (99.4°F), pulse is 110/min, respirations are 18/min, and blood pressure is 150/70 mm Hg. Examination shows moist palms. Neurologic examination shows a fine resting tremor of the hands. Deep tendon reflexes are 3+ with a shortened relaxation phase. Which of the following is the most likely cause of this patient's symptoms?
Q68
A 9-month-old baby boy is brought to his pediatrician due to poor feeding and fewer bowel movements. His father notes that he has been less active and is having difficulty with movements such as rolling over. Vital signs are normal, and physical exam is notable for weak sucking reflex, ptosis, and decreased eye movements. In addition, the baby has generalized weakness and flushed skin. Stool samples are collected, treatment is started immediately, and the baby’s condition improves. The results of the stool studies return several days later and show gram-positive, anaerobic rods. The toxin most likely responsible for this baby’s condition acts through which mechanism?
Q69
A 24-year-old man with a history of schizophrenia presents for follow-up. The patient says that he is still having paranoia and visual hallucinations on his latest atypical antipsychotic medication. Past medical history is significant for schizophrenia diagnosed 1 year ago that failed to be adequately controlled on 2 separate atypical antipsychotic medications. The patient is switched to a typical antipsychotic medication. Which of the following is the mechanism of action of the medication that was most likely prescribed for this patient?
Q70
A 34-year-old woman is brought to the emergency department because of a 3-hour history of weakness, agitation, and slurred speech. She speaks slowly with frequent breaks and has difficulty keeping her eyes open. Over the past three days, she has had a sore throat, a runny nose, and a low-grade fever. She says her eyes and tongue have been “heavy” for the past year. She goes to bed early because she feels too tired to talk or watch TV after dinner. She appears pale and anxious. Her temperature is 38.0°C (100.4°F), pulse is 108/min, respirations are 26/min and shallow, and blood pressure is 118/65 mm Hg. On physical examination, there is bluish discoloration of her lips and around the mouth. Her nostrils dilate with every breath. The lungs are clear to auscultation. There is generalized weakness of the proximal muscles. Which of the following is the most appropriate next step in management?
Cholinergic/Adrenergic drugs US Medical PG Practice Questions and MCQs
Question 61: A 32-year-old farmer is brought to the emergency department by his wife. The patient was reportedly anxious, sweaty, and complaining of a headache and chest tightness before losing consciousness on route to the hospital. Which of the following is mechanistically responsible for this patient's symptoms?
A. Reversible inhibition of acetylcholinesterase
B. Competitive inhibition of acetylcholine at post-junctional effector sites
C. Binding of acetylcholine agonists to post-junctional receptors
D. Irreversible inhibition of acetylcholinesterase (Correct Answer)
E. Inhibition of presynaptic exocytosis of acetylcholine vesicles
Explanation: ***Irreversible inhibition of acetylcholinesterase***
- The farmer's symptoms (anxiety, sweating, headache, chest tightness, loss of consciousness) are characteristic of **organophosphate poisoning**, which causes a cholinergic crisis due to accumulation of acetylcholine.
- Organophosphates are common in **pesticides** and act by irreversibly inhibiting **acetylcholinesterase**, leading to prolonged stimulation of cholinergic receptors.
*Reversible inhibition of acetylcholinesterase*
- Reversible acetylcholinesterase inhibitors, such as **physostigmine** or **neostigmine**, typically have a shorter duration of action and might cause similar symptoms but are less likely to lead to such severe, acute presentations in an accidental exposure scenario for a farmer.
- These agents are often used therapeutically and would not typically cause prolonged loss of consciousness in this context unless in very high intentional doses.
*Competitive inhibition of acetylcholine at post-junctional effector sites*
- This mechanism describes the action of **anticholinergic drugs** (e.g., atropine), which would block acetylcholine's effects and cause symptoms like dry mouth, dilated pupils, and tachycardia, opposite to what is observed here.
- Such agents would alleviate, not cause, the cholinergic symptoms seen in this patient.
*Binding of acetylcholine agonists to post-junctional receptors*
- While direct agonists (e.g., pilocarpine, methacholine) would mimic acetylcholine and cause cholinergic symptoms, organophosphate poisoning operates by preventing acetylcholine breakdown, rather than directly binding as an exogenous agonist.
- The context of a farmer and sudden, severe symptoms points more strongly to pesticide exposure and acetylcholinesterase inhibition.
*Inhibition of presynaptic exocytosis of acetylcholine vesicles*
- This mechanism is characteristic of **botulinum toxin**, which blocks the release of acetylcholine from presynaptic terminals, leading to muscle paralysis and weakness.
- The patient's symptoms are those of cholinergic excess, not cholinergic blockade or deficiency at the neuromuscular junction.
Question 62: A drug research team has synthesized a novel oral drug that acts as an agonist at multiple adrenergic receptors. When administered in animals, it has been shown to produce urinary retention at therapeutic doses with the absence of other manifestations of adrenergic stimulation. The researchers are interested in understanding signal transduction and molecular mechanisms behind the action of the novel drug. Which of the following receptors would most likely transduce signals across the plasma membrane following the administration of this novel drug?
A. GoPCRs (Go protein-coupled receptors)
B. GsPCRs (Gs protein-coupled receptors)
C. GqPCRs (Gq protein-coupled receptors) (Correct Answer)
D. GtPCRs (Gt protein-coupled receptors)
E. GiPCRs (Gi protein-coupled receptors)
Explanation: ***GqPCRs (Gq protein-coupled receptors)***
- **Urinary retention** is primarily mediated by the activation of **alpha-1 adrenergic receptors** in the bladder neck and prostate, which are classically Gq-protein coupled receptors.
- Activation of **GqPCRs** leads to the activation of **phospholipase C**, increased **IP3 (inositol trisphosphate)** and **DAG (diacylglycerol)**, and subsequently, a rise in intracellular **calcium**, causing smooth muscle contraction.
*GoPCRs (Go protein-coupled receptors)*
- While Go proteins are a subtype of Gi/Go family, their direct primary role in mediating **urinary retention** via **adrenergic agonism** is not as well-established as Gq.
- Go signaling often involves modulation of **ion channels** and can be involved in neuronal signaling, not directly causing smooth muscle contraction in the bladder.
*GsPCRs (Gs protein-coupled receptors)*
- **GsPCRs** (e.g., beta-adrenergic receptors) activate **adenylate cyclase**, leading to increased **cAMP** levels, which typically causes smooth muscle relaxation.
- This effect would promote **urinary relaxation** and flow, not retention, and hence is contrary to the observed drug effect.
*GtPCRs (Gt protein-coupled receptors)*
- **GtPCRs** (transducin) are primarily involved in the **phototransduction** cascade in the retina, mediating vision.
- They have no known central role in mediating adrenergic effects on the **urinary tract smooth muscle**.
*GiPCRs (Gi protein-coupled receptors)*
- **GiPCRs** (e.g., alpha-2 adrenergic receptors) inhibit **adenylate cyclase**, leading to decreased **cAMP** levels, which generally causes smooth muscle contraction in some tissues, but also presynaptic inhibition.
- While Gi activation can lead to contraction in some contexts, the primary mechanism of **urinary retention** via bladder neck contraction is through alpha-1 receptors linked to Gq.
Question 63: A 20-year-old man visits the clinic for a regular follow-up appointment. Patient says he has been experiencing dry mouth and flushing of his skin for the past few days. He also feels tired and sleepy most of the time. Past medical history is significant for a skin rash a couple weeks ago after eating strawberries, for which he has prescribed a medication that he is still taking. Which of the following is the most likely etiology of this patient’s symptoms?
A. Inhibition of parasympathetic receptors (Correct Answer)
B. Inhibition of histamine receptors
C. Inhibition of alpha-1 adrenergic receptors
D. Activation of parasympathetic receptors
E. Activation of alpha-1 adrenergic receptors
Explanation: ***Inhibition of parasympathetic receptors***
- The patient's symptoms of **dry mouth**, **flushing**, **fatigue**, and **somnolence** are characteristic side effects of **anticholinergic** medications.
- Many **first-generation antihistamines**, often prescribed for allergic reactions like the patient's rash, have significant **anticholinergic properties** due to their antagonism of **muscarinic acetylcholine receptors**.
*Inhibition of histamine receptors*
- While antihistamines **inhibit histamine receptors** (specifically H1 receptors), this action primarily leads to relief of allergic symptoms like rash, itching, and rhinorrhea.
- The symptoms of dry mouth, flushing, and somnolence are not directly caused by H1 receptor blockade itself but rather by the **additional anticholinergic effects** of older antihistamines.
*Inhibition of alpha-1 adrenergic receptors*
- **Alpha-1 adrenergic receptor inhibition** typically causes **vasodilation**, which can lead to orthostatic hypotension, dizziness, and reflex tachycardia, but not explicitly dry mouth or significant flushing as described.
- This mechanism is characteristic of medications like **alpha-blockers** used for hypertension or benign prostatic hyperplasia, not typically antihistamines.
*Activation of parasympathetic receptors*
- **Activation of parasympathetic receptors** (cholinergic effects) would produce symptoms opposite to those observed, such as increased salivation (not dry mouth), sweating, bradycardia, and miosis.
- This effect is seen with **cholinergic agonists**, not with the antihistamines likely prescribed for an allergic rash.
*Activation of alpha-1 adrenergic receptors*
- **Activation of alpha-1 adrenergic receptors** leads to **vasoconstriction**, increased peripheral resistance, and mydriasis (pupil dilation).
- This would cause symptoms like pallor and hypertension, which are contrary to the patient's reported flushing and fatigue.
Question 64: A 35-year-old man comes to the physician because of dull abdominal pain on his right side for 4 months. He also reports episodic nausea and vomiting during this period. He does not have fever, altered bowel habits, or weight loss. He has had a pet dog for 8 years. He appears healthy. Vital signs are within normal limits. Abdominal examination shows a nontender mass 3 cm below the right costal margin that moves with respiration. Laboratory studies show:
Hemoglobin 14.6 g/dL
Leukocyte count 7200/mm3
Segmented neutrophils 58%
Eosinophils 8%
Lymphocytes 30%
Monocytes 4%
Ultrasound of the abdomen shows a focal hypoechoic cyst within the liver measuring 7 cm. An ELISA confirms the diagnosis. He is scheduled for CT-guided percutaneous drainage under general anesthesia with orotracheal intubation. Seven minutes into the procedure, the patient's oxygen saturation suddenly decreases from 95% to 64%. His heart rate is 136/min, and blood pressure is 86/58 mm Hg. Examination shows diffuse expiratory wheezing bilaterally with poor air movement. Which of the following is most appropriate next step in management?
A. Cricothyrotomy
B. Exploratory laparotomy
C. Epinephrine (Correct Answer)
D. Chest tube insertion
E. Norepinephrine
Explanation: ***Epinephrine***
- The sudden onset of **hypoxemia**, **hypotension**, and **tachycardia** in a patient undergoing a procedure, especially one involving fluid aspiration from a parasitic cyst, strongly suggests **anaphylaxis** due to hypersensitivity to parasitic antigens.
- **Epinephrine** is the first-line treatment for anaphylaxis due to its alpha-1 agonist effects (increasing blood pressure and decreasing mucosal edema) and beta-2 agonist effects (bronchodilation), which directly address the physiological collapse.
*Cricothyrotomy*
- This procedure is indicated for **upper airway obstruction** that cannot be managed by other means, such as failed intubation or severe laryngeal edema.
- While the patient has respiratory compromise, the absent breath sounds and rapidly decreasing oxygen saturation suggest bronchospasm and systemic vasodilation, not primarily a mechanical upper airway obstruction amenable to cricothyrotomy.
*Exploratory laparotomy*
- This is a surgical procedure to investigate the abdominal cavity and is not indicated for an acute, life-threatening allergic reaction.
- It would not address the patient's immediate respiratory or circulatory collapse.
*Chest tube insertion*
- **Chest tube insertion** is used to treat conditions like **pneumothorax** or **hemothorax**, which would typically present with unilateral absent breath sounds or other specific findings.
- The bilateral absent breath sounds and rapidly declining systemic condition are more consistent with severe bronchospasm from anaphylaxis rather than a tension pneumothorax.
*Norepinephrine*
- **Norepinephrine** is a powerful vasopressor primarily used to treat **hypotension** in distributive shock.
- While it can raise blood pressure, it lacks the critical bronchodilatory effects of epinephrine, which are essential in managing the severe bronchospasm seen in anaphylaxis.
Question 65: A 24-year-old woman presents to her primary care physician for bilateral nipple discharge. She states that this started recently and seems to be worsening. She denies any other current symptoms. The patient states that she is not currently sexually active, and her last menstrual period was over a month ago. Her medical history is notable for atopic dermatitis and a recent hospitalization for an episode of psychosis. Her temperature is 99.5°F (37.5°C), blood pressure is 110/65 mmHg, pulse is 70/min, respirations are 15/min, and oxygen saturation is 98% on room air. Cardiopulmonary and abdominal exam are within normal limits. Which of the following is the most likely cause of this patient's symptoms?
A. Prolactin-secreting mass
B. Alteration of the tuberoinfundibular pathway (Correct Answer)
C. Alteration of the nigrostriatal pathway
D. Normal pregnancy
E. Alteration of the mesolimbic pathway
Explanation: ***Alteration of the tuberoinfundibular pathway***
- Bilateral nipple discharge (galactorrhea) in this patient, especially after a recent hospitalization for psychosis, is highly suggestive of **hyperprolactinemia** caused by antipsychotic medication. Antipsychotics block dopamine D2 receptors in the **tuberoinfundibular pathway**, leading to increased prolactin secretion.
- The patient's history of psychosis indicates she is likely on **antipsychotic medication**, which is a common cause of drug-induced hyperprolactinemia and galactorrhea.
*Prolactin-secreting mass*
- While a **prolactinoma** can cause galactorrhea, it typically presents with more pronounced symptoms (e.g., visual field defects, headaches, amenorrhea) and is a diagnosis of exclusion after ruling out more common causes like medication.
- Given the **history of psychosis** and recent hospitalization, drug-induced hyperprolactinemia is a more immediate and likely explanation than a pituitary tumor.
*Alteration of the nigrostriatal pathway*
- Alteration of the **nigrostriatal pathway** is primarily associated with **extrapyramidal symptoms** (e.g., parkinsonism, dystonia, akathisia) due to dopamine receptor blockade by antipsychotics.
- This pathway's dysfunction does not directly cause galactorrhea or hyperprolactinemia.
*Normal pregnancy*
- Although **pregnancy** causes galactorrhea due to elevated prolactin levels, the patient's statement of "not currently sexually active" and only a "last menstrual period was over a month ago" makes it less likely than drug-induced hyperprolactinemia given her medical history.
- While a pregnancy test would be part of the workup, her current symptoms and medical history point more strongly to **medication-induced effects**.
*Alteration of the mesolimbic pathway*
- The **mesolimbic pathway** is primarily involved in reward, motivation, and psychosis; its hyperactivity is implicated in the positive symptoms of **schizophrenia**.
- While antipsychotics target this pathway to reduce psychotic symptoms, its alteration per se does not directly cause galactorrhea.
Question 66: A 19-year-old man is brought to the emergency department by his mother because of increasing agitation and aggression at home. He has a history of bipolar disorder. During the last week, he has refused to take his lithium medication because it makes him “feel empty inside.” The mother thinks he has experimented with illicit drugs in the past. He appears acutely agitated, yells at multiple medical staff members, and demands to be discharged. His temperature is 37.7°C (99.8°F), pulse is 95/min, respirations are 18/min, and blood pressure is 140/75 mm Hg. Haloperidol is administered and the patient is admitted. The next morning, the patient reports worsening neck pain. He states that his neck is locked to the left and he cannot move it. Examination shows rigidity of his upper body and neck, with the neck fixed in flexion and rotated to the left. Administration of which of the following is the most appropriate next step in the management of this patient?
A. Bromocriptine
B. Physostigmine
C. Botulinum toxin
D. Benztropine (Correct Answer)
E. Diazepam
Explanation: ***Benztropine***
- The patient is experiencing an acute **dystonic reaction** due to haloperidol, presenting with severe neck rigidity, flexion, and rotation (torticollis).
- **Benztropine**, an anticholinergic medication, is the first-line treatment for acute dystonia as it blocks muscarinic receptors and restores the **acetylcholine-dopamine balance**.
*Bromocriptine*
- This is a **dopamine agonist** typically used to treat **neuroleptic malignant syndrome (NMS)**, which presents with fever, severe muscle rigidity, autonomic instability, and altered mental status.
- The patient's symptoms are more consistent with acute dystonia, not NMS, and his temperature is only mildly elevated.
*Physostigmine*
- This is an **acetylcholinesterase inhibitor** used to reverse anticholinergic toxicity, which would present with symptoms like dry mouth, blurred vision, delirium, and urinary retention.
- The patient's symptoms of acute dystonia are caused by **dopamine blockade** leading to a **relative excess of cholinergic activity**, not anticholinergic poisoning.
*Botulinum toxin*
- While effective for chronic dystonia and muscle spasms, **botulinum toxin** is not the appropriate first-line treatment for an acute drug-induced dystonic reaction.
- Its effects are not immediate, and it is usually reserved for cases refractory to oral medications or for focal dystonias.
*Diazepam*
- As a **benzodiazepine**, diazepam can provide some muscle relaxation and reduce anxiety, but it is not the primary treatment for reversing the neurochemical imbalance causing acute dystonia.
- It could be used as an adjunct for agitation or muscle spasms, but an anticholinergic is directly indicated for dystonia.
Question 67: A previously healthy 25-year-old woman comes to the physician because of a 1-month history of palpitations that occur on minimal exertion and sometimes at rest. She has no chest discomfort or shortness of breath. She feels nervous and irritable most of the time and attributes these feelings to her boyfriend leaving her 2 months ago. Since then she has started exercising more frequently and taking an herbal weight-loss pill, since which she has lost 6.8 kg (15 lb) of weight. She finds it hard to fall asleep and awakens 1 hour before the alarm goes off each morning. She has been drinking 2 to 3 cups of coffee daily for the past 7 years and has smoked one pack of cigarettes daily for the past 3 years. Her temperature is 37.4°C (99.4°F), pulse is 110/min, respirations are 18/min, and blood pressure is 150/70 mm Hg. Examination shows moist palms. Neurologic examination shows a fine resting tremor of the hands. Deep tendon reflexes are 3+ with a shortened relaxation phase. Which of the following is the most likely cause of this patient's symptoms?
A. Exogenous hyperthyroidism (Correct Answer)
B. Pheochromocytoma
C. Hashimoto thyroiditis
D. Coffee consumption
E. Generalized anxiety disorder
Explanation: ***Exogenous hyperthyroidism***
- The patient's symptoms including **palpitations, weight loss, nervousness, irritability, insomnia**, and physical findings like **tachycardia, moist palms, fine tremor**, and **hyperreflexia with shortened relaxation phase** are highly indicative of **hyperthyroidism**.
- The use of an **herbal weight-loss pill** strongly suggests the possibility of exogenous thyroid hormone intake or other thyroid-stimulating substances within the pill, leading to **exogenous hyperthyroidism**.
*Pheochromocytoma*
- While **palpitations** and **hypertension** can occur, **pheochromocytoma** is typically characterized by paroxysmal episodes of severe headaches, sweating, and anxiety.
- The chronic nature of the patient's symptoms, along with significant **weight loss** and **hyperreflexia**, are less typical for **pheochromocytoma**.
*Hashimoto thyroiditis*
- **Hashimoto thyroiditis** typically causes **hypothyroidism**, characterized by symptoms like weight gain, fatigue, cold intolerance, and bradycardia.
- While it can sometimes have a transient hyperthyroid phase (hashitoxicosis), the overall clinical picture here is more consistent with sustained **hyperthyroidism**, especially given the suspected external factor.
*Coffee consumption*
- Although **caffeine** can cause palpitations, nervousness, and insomnia, the severity and breadth of this patient's symptoms, including significant **weight loss, hyperreflexia**, and **moist palms**, extend far beyond what would typically be attributed solely to coffee intake, especially given her chronic coffee use.
- The new onset and progression of these symptoms, coinciding with the herbal pill, points to a stronger underlying cause.
*Generalized anxiety disorder*
- **Generalized anxiety disorder (GAD)** can explain nervousness, irritability, and insomnia, but it does not typically cause **significant weight loss** or objective physical findings such as **tachycardia, moist palms, fine tremor, and hyperreflexia**.
- These physical signs are hallmarks of a physiological rather than purely psychological condition.
Question 68: A 9-month-old baby boy is brought to his pediatrician due to poor feeding and fewer bowel movements. His father notes that he has been less active and is having difficulty with movements such as rolling over. Vital signs are normal, and physical exam is notable for weak sucking reflex, ptosis, and decreased eye movements. In addition, the baby has generalized weakness and flushed skin. Stool samples are collected, treatment is started immediately, and the baby’s condition improves. The results of the stool studies return several days later and show gram-positive, anaerobic rods. The toxin most likely responsible for this baby’s condition acts through which mechanism?
A. Impairment of phagocytosis
B. Increased chloride secretion within the gut
C. Inhibition of protein synthesis
D. Inhibition of neurotransmitter release (Correct Answer)
E. Degradation of the cell membrane
Explanation: ***Inhibition of neurotransmitter release***
- The baby's symptoms of **generalized weakness**, **weak sucking reflex**, **ptosis**, and **decreased eye movements** are characteristic of **infant botulism**, caused by *Clostridium botulinum* toxins.
- These toxins, specifically the **botulinum neurotoxin**, block the release of **acetylcholine** at the **neuromuscular junction**, leading to flaccid paralysis.
*Impairment of phagocytosis*
- This mechanism is not directly related to the symptoms of **flaccid paralysis** seen in infant botulism.
- Phagocytosis is primarily involved in immune responses and pathogen clearance, not nerve transmission.
*Increased chloride secretion within the gut*
- While some bacterial toxins, like **cholera toxin**, cause increased chloride secretion leading to watery diarrhea, this is not the mechanism of botulinum toxin.
- The baby's symptoms point to neurological impairment, not excessive fluid loss in the gut.
*Inhibition of protein synthesis*
- Toxins such as **diphtheria toxin** or **Shiga toxin** inhibit protein synthesis, leading to cell death and specific clinical manifestations different from those presented here.
- The symptoms described are due to a highly specific blockage of neurotransmission rather than general cellular dysfunction.
*Degradation of the cell membrane*
- This mechanism is characteristic of toxins that form **pores** or enzymes that directly **damage cell membranes**, leading to cell lysis.
- Examples include alpha-toxin of *Clostridium perfringens*, but it does not align with the neurological symptoms of infant botulism.
Question 69: A 24-year-old man with a history of schizophrenia presents for follow-up. The patient says that he is still having paranoia and visual hallucinations on his latest atypical antipsychotic medication. Past medical history is significant for schizophrenia diagnosed 1 year ago that failed to be adequately controlled on 2 separate atypical antipsychotic medications. The patient is switched to a typical antipsychotic medication. Which of the following is the mechanism of action of the medication that was most likely prescribed for this patient?
A. Dopaminergic receptor antagonist (Correct Answer)
B. Dopaminergic partial agonist
C. Serotonergic receptor agonist
D. Serotonergic receptor antagonist
E. Cholinergic receptor agonist
Explanation: ***Dopaminergic receptor antagonist***
- The patient has **treatment-resistant schizophrenia**, indicated by failure to respond to two different atypical antipsychotics.
- Typical antipsychotics like **haloperidol** or **fluphenazine** are primarily **D2 dopamine receptor antagonists**, which may be used when a patient has not responded to atypical agents.
- The **primary mechanism** of typical (first-generation) antipsychotics is **potent D2 receptor blockade** in the mesolimbic pathway, which reduces positive symptoms of schizophrenia.
- Note: Clozapine would be the preferred choice for true treatment-resistant schizophrenia, but typical antipsychotics may still be considered in some clinical scenarios.
*Dopaminergic partial agonist*
- **Dopamine partial agonists**, such as **aripiprazole** or **brexpiprazole**, are **atypical antipsychotics** used for schizophrenia.
- The patient has failed to respond to atypical antipsychotics already, making it unlikely that another atypical agent would be the next choice.
- The question specifically states the patient is switched to a **typical antipsychotic**.
*Serotonergic receptor agonist*
- **Serotonin receptor agonists**, like LSD or psilocybin, are **not used** in the treatment of schizophrenia; they can, in fact, **induce psychotic symptoms**.
- While some antipsychotics modulate serotonin receptors, their therapeutic effect is not through agonism of these receptors.
*Serotonergic receptor antagonist*
- Many **atypical antipsychotics** have significant **serotonin 5-HT2A receptor antagonist** activity, in addition to D2 antagonism.
- However, the question states that the patient is being switched to a **typical antipsychotic**, whose primary and defining mechanism is **D2 antagonism**, not combined serotonin-dopamine antagonism.
*Cholinergic receptor agonist*
- **Cholinergic receptor agonists** are **not used** to treat schizophrenia and would likely worsen symptoms or cause significant side effects.
- These agents would have no therapeutic benefit in psychosis and are not part of the antipsychotic drug class.
Question 70: A 34-year-old woman is brought to the emergency department because of a 3-hour history of weakness, agitation, and slurred speech. She speaks slowly with frequent breaks and has difficulty keeping her eyes open. Over the past three days, she has had a sore throat, a runny nose, and a low-grade fever. She says her eyes and tongue have been “heavy” for the past year. She goes to bed early because she feels too tired to talk or watch TV after dinner. She appears pale and anxious. Her temperature is 38.0°C (100.4°F), pulse is 108/min, respirations are 26/min and shallow, and blood pressure is 118/65 mm Hg. On physical examination, there is bluish discoloration of her lips and around the mouth. Her nostrils dilate with every breath. The lungs are clear to auscultation. There is generalized weakness of the proximal muscles. Which of the following is the most appropriate next step in management?
A. Intravenous immunoglobulin therapy
B. Administration of edrophonium
C. Endotracheal intubation (Correct Answer)
D. Pyridostigmine therapy
E. Plasmapheresis
Explanation: ***Endotracheal intubation***
- The patient presents with clear signs of **respiratory distress** (tachypnea, shallow breathing, nostril flaring, cyanosis, and slurred speech) which indicates impending **respiratory failure**. This necessitates immediate airway management to prevent further deterioration and ensure adequate oxygenation.
- Though likely a **myasthenic crisis**, the priority is to stabilize the patient's airway and breathing before confirming the diagnosis or initiating definitive treatment.
*Intravenous immunoglobulin therapy*
- **IVIG** is a treatment for **myasthenic crisis**, but it is not the immediate first step when respiratory failure is imminent.
- **IVIG** takes time to administer and show therapeutic effect, making it unsuitable for acute respiratory compromise.
*Administration of edrophonium*
- **Edrophonium (Tensilon test)** is used diagnostically to confirm **myasthenia gravis**, but it is not an appropriate intervention in a patient with acute respiratory failure.
- Administering **edrophonium** could worsen respiratory symptoms by causing cholinergic effects, such as increased secretions, and should not be used in an unstable patient.
*Pyridostigmine therapy*
- **Pyridostigmine** is a long-term treatment for **myasthenia gravis** to improve muscle strength, but it is too slow-acting for acute crisis management.
- Increasing the dose of **pyridostigmine** could potentially precipitate a **cholinergic crisis**, further complicating the patient's respiratory status.
*Plasmapheresis*
- **Plasmapheresis** is an effective treatment for **myasthenic crisis**, but like **IVIG**, it is not an immediate life-saving measure for acute respiratory failure.
- It requires setup and time, during which the patient's respiratory status could dangerously decline.
